MPH Health Care AG (FRA:93M1)
Germany · Delayed Price · Currency is EUR 28.50
+0.10 (0.35%)
At close: Nov 4, 2026
MPH Health Care AG Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 122 | 96 | 96 | 70 | 61 | 89 | |
Market Cap Growth | 56.59% | 0% | 36.59% | 15.49% | -31.40% | -9.21% |
Enterprise Value | 135 | 105 | 97 | 70 | 57 | 88 |
Last Close Price | 28.40 | 18.46 | 17.31 | 12.07 | 10.45 | 15.23 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 2.51 | - | 2.99 | 2.38 | 2.09 | - |
Forward PE | 3.26 | 21.50 | 16.64 | 23.26 | 19.80 | 19.12 |
PS Ratio | 2.40 | 1.91 | 1.47 | 2.04 | 1.99 | 6.56 |
PB Ratio | 0.49 | 0.39 | 0.35 | 0.28 | 0.28 | 0.46 |
P/TBV Ratio | 0.49 | 0.39 | 0.35 | 0.28 | 0.28 | 0.46 |
P/FCF Ratio | 32.32 | 779.61 | 52.54 | - | - | - |
P/OCF Ratio | 32.25 | 732.78 | 52.42 | - | 16083.51 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.65 | 2.09 | 1.48 | 2.03 | 1.85 | 6.55 |
EV/EBITDA Ratio | 2.72 | 2.15 | 1.51 | 2.10 | 1.91 | 7.01 |
EV/EBIT Ratio | 2.72 | 2.15 | 1.51 | 2.10 | 1.91 | 7.02 |
EV/FCF Ratio | 35.65 | 853.32 | 53.09 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.06 | 0.05 | 0.04 | 0.05 | 0.06 | 0.02 |
Debt / EBITDA Ratio | 0.31 | 0.24 | 0.16 | 0.39 | 0.44 | 0.32 |
Debt / FCF Ratio | 4.08 | 94.56 | 5.73 | - | - | - |
Net Debt / Equity Ratio | 0.05 | 0.04 | 0.03 | 0.03 | 0.04 | 0.00 |
Net Debt / EBITDA Ratio | 0.26 | 0.21 | 0.14 | 0.24 | 0.31 | -0.03 |
Net Debt / FCF Ratio | 3.34 | 83.39 | 5.08 | -3.94 | -4995.28 | 0.37 |
Asset Turnover | 0.21 | 0.18 | 0.23 | 0.14 | 0.14 | 0.07 |
Quick Ratio | 0.18 | 0.16 | 0.51 | 1.37 | 0.28 | 1.06 |
Current Ratio | 0.20 | 0.16 | 0.52 | 1.42 | 0.29 | 1.06 |
Return on Equity (ROE) | 21.36% | -11.25% | 12.12% | 12.51% | 14.07% | -4.55% |
Return on Assets (ROA) | 12.68% | 11.09% | 14.40% | 8.27% | 8.52% | 3.85% |
Return on Invested Capital (ROIC) | 18.53% | 18.02% | 23.31% | 13.50% | 13.87% | 6.43% |
Return on Capital Employed (ROCE) | 19.60% | 19.50% | 22.50% | 12.70% | 13.30% | 6.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 39.83% | -30.58% | 33.41% | 42.08% | 47.89% | -10.11% |
FCF Yield | 3.09% | 0.13% | 1.90% | -2.88% | -0.00% | -1.23% |
Dividend Yield | 17.54% | 22.32% | 5.36% | 7.32% | - | - |
Payout Ratio | 10.61% | - | 16.03% | - | - | - |
Total Shareholder Return | 17.61% | 22.32% | 5.36% | 7.32% | - | - |